Elevance Health's Q1 results showed stable Medicare utilization and reaffirmed guidance. Click here to find out why ELV stock ...

Elevance posted mixed results for the first quarter but reaffirmed its 2025 earnings outlook, solidifying guidance it published early to pacify investors after UnitedHealth posted dismal results last ...

The program now serves 6 million patients, and Elevance sees it as something that sets it apart from the competition.

We recently published a list of 10 Best Stocks That Will Always Grow. In this article, we are going to take a look at where ...

Q1 2025 Earnings Call Transcript April 22, 2025 Elevance Health Inc. beats earnings expectations. Reported EPS is $11.97, ...

RBC Capital analyst Ben Hendrix maintained a Buy rating on Elevance Health (ELV – Research Report) today and set a price target of $478.00. The ...

Barclays raised the firm’s price target on Elevance Health (ELV) to $522 from $512 and keeps an Overweight rating on the shares following the ...

Elevance Health flexed its financial muscles in Q1 2025, reporting a 15.4% jump in revenue to $48.8 billion, driven by ...

The stock's rise snapped a four-day losing streak.

A surprising Medicare Advantage cost spike helped push UnitedHealth into a rare deep dive Thursday, after the health care ...

The warning sign from a healthcare giant seen as the insurance industry’s bellwether may mean trouble for companies with ...

UnitedHealth Group shares plunged more than 20% Thursday after the insurer slashed its full-year profit forecast, citing ...